Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 49 Records) |
Query Trace: Leukemia and ABCG2[original query] |
---|
Influence of pre-hydration and pharmacogenetics on plasma methotrexate concentration and renal dysfunction following high-dose methotrexate therapy. International journal of hematology 2013 Dec 98 (6): 702-7. Yanagimachi Masakatsu, Goto Hiroaki, Kaneko Tetsuji, Naruto Takuya, Sasaki Koji, Takeuchi Masanobu, Tanoshima Reo, Kato Hiromi, Yokosuka Tomoko, Kajiwara Ryosuke, Fujii Hisaki, Tanaka Fumiko, Goto Shoko, Takahashi Hiroyuki, Mori Masaaki, Kai Sumio, Yokota Shump |
High imatinib dose overcomes insufficient response associated with ABCG2 haplotype in chronic myelogenous leukemia patients. Oncotarget 2013 Oct 4 (10): 1582-91. Delord Marc, Rousselot Philippe, Cayuela Jean Michel, Sigaux François, Guilhot Joëlle, Preudhomme Claude, Guilhot François, Loiseau Pascale, Raffoux Emmanuel, Geromin Daniela, Génin Emmanuelle, Calvo Fabien, Bruzzoni-Giovanelli Heriber |
High-dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next? Journal of cancer research and clinical oncology 2014 Aug 140 (8): 1359-65. El Mesallamy Hala O, Rashed Wafaa M, Hamdy Nadia M, Hamdy Naye |
The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia. The pharmacogenomics journal 2014 Aug 14 (4): 328-35. Di Paolo A, Polillo M, Capecchi M, Cervetti G, Baratè C, Angelini S, Guerrini F, Fontanelli G, Arici R, Ciabatti E, Grassi S, Bocci G, Hrelia P, Danesi R, Petrini M, Galimberti |
Association of genotypes and haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patients. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2014 Apr 68 (3): 343-9. Au Anthony, Aziz Baba Abdul, Goh Ai Sim, Wahid Fadilah S Abdul, Teh Alan, Rosline Hassan, Ankathil Ravindr |
Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies. Pharmacogenomics 2014 Aug 15 (11): 1479-94. Suthandiram Sujatha, Gan Gin-Gin, Zain Shamsul Mohd, Bee Ping-Chong, Lian Lay-Hoong, Chang Kian-Meng, Ong Tee-Chuan, Mohamed Zahur |
Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia. Medical oncology (Northwood, London, England) 2014 Mar 31 (3): 851. de Lima Luciene Terezina, Vivona Douglas, Bueno Carolina Tosin, Hirata Rosario D C, Hirata Mario H, Luchessi André D, de Castro Fabíola Attié, de Lourdes F Chauffaille Maria, Zanichelli Maria A, Chiattone Carlos S, Hungria Vania T M, Guerra-Shinohara Elvira |
Concurrent effects of ABCB1 C3435T, ABCG2 C421A, and XRCC1 Arg194Trp genetic polymorphisms with risk of cancer, clinical output, and response to treatment with imatinib mesylate in patients with chronic myeloid leukemia. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Aug . Salimizand Hana, Amini Sabrieh, Abdi Mohammad, Ghaderi Bayazid, Azadi Namam-A |
Influence of Sokal, Hasford, EUTOS scores and pharmacogenetic factors on the complete cytogenetic response at 1 year in chronic myeloid leukemia patients treated with imatinib. Medical oncology (Northwood, London, England) 2015 Aug 32 (8): 213. Francis Jose, Dubashi Biswajit, Sundaram Rajan, Pradhan Suresh Chandra, Chandrasekaran Adith |
A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients. Cancer chemotherapy and pharmacology 2015 Nov . Francis Jose, Dubashi Biswajit, Sundaram Rajan, Pradhan Suresh Chandra, Chandrasekaran Adith |
Trough concentration and ABCG2 polymorphism are better to predict imatinib response in chronic myeloid leukemia: a meta-analysis. Pharmacogenomics 2017 Jan 18 (1): 35-56. Jiang Zhi-Ping, Zhao Xie-Lan, Takahashi Naoto, Angelini Sabrina, Dubashi Biswajit, Sun Li, Xu Pi |
Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia. Leukemia & lymphoma 2016 Oct 1-10. Megías-Vericat Juan Eduardo, Montesinos Pau, Herrero María José, Moscardó Federico, Bosó Virginia, Rojas Luis, Martínez-Cuadrón David, Hervás David, Boluda Blanca, García-Robles Ana, Rodríguez-Veiga Rebeca, Martín-Cerezuela María, Cervera José, Sendra Luis, Sanz Jaime, Miguel Antonio, Lorenzo Ignacio, Poveda José Luis, Sanz Miguel Ángel, Aliño Salvador |
Population pharmacokinetics of Daunorubicin in adult patients with acute myeloid leukemia. Cancer chemotherapy and pharmacology 2016 Oct . Varatharajan Savitha, Panetta John C, Abraham Ajay, Karathedath Sreeja, Mohanan Ezhilpavai, Lakshmi Kavitha M, Arthur Nancy, Srivastava Vivi M, Nemani Sandeep, George Biju, Srivastava Alok, Mathews Vikram, Balasubramanian Poonkuzha |
Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia. Current drug metabolism 2017 11 19 (1): 55-74. Megias-Vericat Juan Eduardo, Martinez-Cuadron David, Herrero Maria Jose, Alino Salvador F, Poveda Jose Luis, Sanz Miguel Angel, Montesinos P |
Effects of polymorphisms in NR1I2, CYP3A4, and ABC transporters on the steady-state plasma trough concentrations of bosutinib in Japanese patient with chronic myeloid leukemia. Medical oncology (Northwood, London, England) 2018 May 35 (6): 90. Abumiya Maiko, Mita Akiko, Takahashi Saori, Yoshioka Tomoko, Kameoka Yoshihiro, Takahashi Naoto, Miura Masato |
The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients. Archives of medical science : AMS 2018 Oct 14 (6): 1416-1423. Belohlavkova Petra, Vrbacky Filip, Voglova Jaroslava, Racil Zdenek, Zackova Daniela, Hrochova Katerina, Malakova Jana, Mayer Jiri, Zak Pav |
Association of the Trough, Peak/Trough Ratio of Imatinib, Pyridine-N-Oxide Imatinib and ABCG2 SNPs 34 G>A and SLCO1B3 334 T>G With Imatinib Response in Egyptian Chronic Myeloid Leukemia Patients. Frontiers in oncology 2020 9 10 1348. Omran Mervat M, Abdelfattah Raafat, Moussa Heba S, Alieldin Nelly, Shouman Samia |
Polymorphisms within methotrexate pathway genes: Relationship between plasma methotrexate levels, toxicity experienced and outcome in pediatric acute lymphoblastic leukemia. Iranian journal of basic medical sciences 2020 Jun 23 (6): 800-809. Esmaili Mohammad Ali, Kazemi Ahmad, Faranoush Mohammad, Mellstedt Hakan, Zaker Farhad, Safa Majid, Mehrvar Narjes, Rezvany Mohammad Re |
Effects of Trough Concentration and Solute Carrier Polymorphisms on Imatinib Efficacy in Chinese Patients with Chronic Myeloid Leukemia. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 2020 23 (1): 1-9. Wang Qing, Jiang Zhi-Ping, Zeng Jing, Zhu Yan, Cai Hua-Lin, Xiang Da-Xiong, He Qun, Shi Xiao-Liu, Zhong An-Ni, Zhao Xie-Lan, Xu Pi |
Genetic factors in treatment-related cardiovascular complications in survivors of childhood acute lymphoblastic leukemia. Pharmacogenomics 2021 9 22 (14): 885-901. Petrykey Kateryna, Rezgui Aziz M, Guern Mathilde Le, Beaulieu Patrick, St-Onge Pascal, Drouin Simon, Bertout Laurence, Wang Fan, Baedke Jessica L, Yasui Yutaka, Hudson Melissa M, Raboisson Marie-Josée, Laverdière Caroline, Sinnett Daniel, Andelfinger Gregor U, Krajinovic Ma |
Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib. Frontiers in oncology 2021 11 672287. Loscocco Federica, Visani Giuseppe, Ruzzo Annamaria, Bagaloni Irene, Fuligni Fabio, Galimberti Sara, Di Paolo Antonello, Stagno Fabio, Pregno Patrizia, Annunziata Mario, Gozzini Antonella, Barulli Sara, Gabucci Elisa, Magnani Mauro, Isidori Alessand |
Pharmacogenetics of induction therapy-related toxicities in childhood acute lymphoblastic leukemia patients treated with UKALL 2003 protocol. Scientific reports 2021 12 11 (1): 23757. Aslam Sara, Ameer Sonia, Shabana N A, Ahmed Mehbo |
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia. Pharmaceutics 2022 4 14 (4): . Megías-Vericat Juan Eduardo, Martínez-Cuadrón David, Solana-Altabella Antonio, Poveda José Luis, Montesinos P |
Effects of splicing-regulatory polymorphisms in ABCC2, ABCG2, and ABCB1 on methotrexate exposure in Chinese children with acute lymphoblastic leukemia. Cancer chemotherapy and pharmacology 2022 12 91 (1): 77-87. Li Miao, Kong Xiao-Yan, Wang Shu-M |
Identification of crucial genes and metabolites regulating the eggshell brownness in chicken. BMC genomics 2022 11 23 (1): 761. Yang Jing, Mao Zhiqiong, Wang Xiqiong, Zhuang Jingjie, Gong Sijia, Gao Zhouyang, Xu Guiyun, Yang Ning, Sun Congji |
Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia. Frontiers in oncology 2022 12 952640. Madejczyk Anna Marta, Canzian Federico, Góra-Tybor Joanna, Campa Daniele, Sacha Tomasz, Link-Lenczowska Dorota, Florek Izabela, Prejzner Witold, Ca?becka M, Rymko M, Dudzi?ski M, Orzechowska Magdalena Julita, Jamroziak Krzyszt |
Population pharmacokinetics and pharmacogenetics analyses of imatinib in Chinese patients with chronic myeloid leukemia in a real-world situation. Cancer chemotherapy and pharmacology 2023 8 . Shiyu He, Qianhang Shao, Jinxia Zhao, Jialu Bian, Yinyu Zhao, Xu Hao, Yuanyuan Li, Lei Hu, Boyu Liu, Huan He, Lin Huang, Qian Jia |
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis. International journal of molecular sciences 2023 2 24 (4): . Dalle Fratte Chiara, Polesel Jerry, Gagno Sara, Posocco Bianca, De Mattia Elena, Roncato Rossana, Orleni Marco, Puglisi Fabio, Guardascione Michela, Buonadonna Angela, Toffoli Giuseppe, Cecchin Eri |
Association of ABCB1, ABCG2 drug transporter polymorphisms and smoking with disease risk and cytogenetic response to imatinib in chronic myeloid leukemia patients. Leukemia research 2023 1 126 107021. Mohammadi Fatemeh, Rostami Golale, Hamid Mohammad, Shafiei Mohammad, Azizi Masoumeh, Bahmani Has |
A Study to Explore the Role of IDH1 (R132) Mutation on Imatinib Toxicity and Effect of ABCG2/OCT1 Expression on N-Desmethyl Imatinib Plasma Level in Egyptian Chronic Myeloid Leukemia Patients. Drug research 2023 1 73 (3): 146-155. Sabri Alaa, Omran Mervat M, Azim S Abdel, Abdelfattah Raafat, Allam Rasha Mahmoud, Shouman Samia |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: